Latest on Pharmaceutical Industry


RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol

RespireRx Pharmaceuticals Inc., a leader in the research and development of cannabinoids for the treatment of sleep-related breathing disorders, is pleased to announce that it has entered into a non-binding memorandum of..Read More...

CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

CRISPR Therapeutic, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV)-based gene ther..Read More...



3D Cell Culture 2019

Copthorne Tara Hotel London Kensington,
United Kingdom,
SMi Group


Medical Japan - Elderly Care & Nursing Expo OSAKA

INTEX Osaka,
Reed Exhibitions Japan Ltd

Press Releases

Pfenex Announces FDA Acceptance of NDA for PF708

Pfenex Inc today announced that the US Food and Drug Administration FDA has accepted for review the 505b2 New Drug Application NDA for the Companys lead product candidate PF708 a Forteo therapeutic equivalent in the trea.. Read More...

Fusion Pharma Announces First Patient Dosing in a Phase 1 Clinical Trial of [225Ac]-FPI-1434 Injection in Patients with Advanced Solid Tumors

Fusion Pharmaceuticals a biopharmaceutical company focused on radiotherapeutics specifically targeted alpha therapeutics today announced that the first patient was dosed in a Phase 1 firstinhuman clinical trial of lead p.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer